[go: up one dir, main page]

ES2000516A6 - Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas - Google Patents

Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas

Info

Publication number
ES2000516A6
ES2000516A6 ES8600341A ES8600341A ES2000516A6 ES 2000516 A6 ES2000516 A6 ES 2000516A6 ES 8600341 A ES8600341 A ES 8600341A ES 8600341 A ES8600341 A ES 8600341A ES 2000516 A6 ES2000516 A6 ES 2000516A6
Authority
ES
Spain
Prior art keywords
beta
carbacephalosporins
trifluoromethylsulfonyloxy
intermediates
lactam antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600341A
Other languages
English (en)
Inventor
David Albert Evans
Eric Brian Sjogren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Publication of ES2000516A6 publication Critical patent/ES2000516A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO ASIMETRICO PARA LA PREPARACION DE 1-CARBACEFALOSPORINAS DE FORMULA GENERAL (X) DONDE R2 Y R6 TIENEN LOS SIGUIENTES SIGNIFICADOS DESCRITOS EN LA MEMORIA, QUE COMPRENDE LA CICLACION DE UN COMPUESTO DE FORMULA 10B CATALIZADA POR RODIO (II).
ES8600341A 1985-07-17 1986-07-16 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas Expired ES2000516A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/755,982 US4665171A (en) 1985-07-17 1985-07-17 Process and intermediates for β-lactam antibiotics

Publications (1)

Publication Number Publication Date
ES2000516A6 true ES2000516A6 (es) 1988-03-01

Family

ID=25041514

Family Applications (2)

Application Number Title Priority Date Filing Date
ES8600341A Expired ES2000516A6 (es) 1985-07-17 1986-07-16 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas
ES8703788A Expired ES2005752A6 (es) 1985-07-17 1987-12-31 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES8703788A Expired ES2005752A6 (es) 1985-07-17 1987-12-31 Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas.

Country Status (22)

Country Link
US (1) US4665171A (es)
EP (2) EP0362902B1 (es)
JP (2) JPH0762015B2 (es)
KR (1) KR900005257B1 (es)
CN (1) CN1015178B (es)
AR (1) AR243186A1 (es)
AT (2) ATE133172T1 (es)
AU (2) AU595216B2 (es)
CA (1) CA1310323C (es)
DE (2) DE3679002D1 (es)
DK (2) DK173456B1 (es)
ES (2) ES2000516A6 (es)
GR (1) GR861857B (es)
HK (1) HK1007140A1 (es)
HU (2) HU906465D0 (es)
IE (1) IE58997B1 (es)
IL (1) IL79420A (es)
NZ (1) NZ216871A (es)
PT (1) PT82989B (es)
RU (1) RU1794079C (es)
SU (1) SU1579460A3 (es)
ZA (1) ZA865274B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870169A (en) * 1985-07-17 1989-09-26 President And Fellows Of Harvard College Intermediates for beta-lactam antibiotics
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
US4734498A (en) * 1986-07-10 1988-03-29 Eli Lilly And Company 3β-succinimidoazetidinones as chiral intermediates
CA1323370C (en) * 1986-09-12 1993-10-19 Davis H. Crater Fluorochemical oxazolidinones
US4782144A (en) * 1987-09-14 1988-11-01 Eli Lilly And Company 1-carba(dethia)-3-hydroxy-3-cephem ester crystalline and crystalline solvate thereof
US5019571A (en) * 1988-01-25 1991-05-28 Eli Lilly And Company 1-carbacephalosporin antibiotics
US4855418A (en) 1988-03-23 1989-08-08 Eli Lilly And Company Process for production of ceophalosporins
US4820832A (en) * 1988-03-23 1989-04-11 Eli Lilly And Company Process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia)cephalosporins
US4885362A (en) * 1988-06-06 1989-12-05 Eli Lilly And Company Azetidinone intermediates for 1-carba(dethia)caphalosporins
JPH0225463A (ja) * 1988-06-06 1990-01-26 Eli Lilly & Co １―カルバ（１―デチア）―３―セフェム―４―カルボン酸の中間体の製造法
EP0345998A1 (en) * 1988-06-06 1989-12-13 Eli Lilly And Company Process and intermediates for beta-lactam antibiotics
ATE104977T1 (de) * 1988-06-22 1994-05-15 Lilly Co Eli Zwischenprodukt fuer 1-carba(dethia)cephalosporin.
KR0169096B1 (ko) * 1988-10-11 1999-01-15 리로이 휘테커 카바세팔로스포린의 아제티디논 중간체 화합물 및 제조방법
US5453503A (en) * 1988-10-11 1995-09-26 Eli Lilly And Company Azetidinone intermediates to carbacephalosporins and process
US4931556A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-(2-furyl)eth-1-yl)-methoxycarbonylmethyl-azetidin-2-one and malic acid salts thereof
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
JPH02252648A (ja) * 1989-03-27 1990-10-11 Naomi Iwagou イオン溶出燒結体
US5106475A (en) * 1989-09-20 1992-04-21 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US4992545A (en) * 1989-09-20 1991-02-12 Eli Lilly And Company Process for preparing 4-substituted azetidinones
US5030725A (en) * 1990-02-06 1991-07-09 Eli Lilly And Company Method of resolving cis 3-amino-4-[2-(2-furyl)eth-1-yl]-1-methoxycarbonylmethyl-azetidin-2-one using (-)-DAG
US5051502A (en) * 1990-06-06 1991-09-24 University Of Notre Dame Du Lac Rhodium catalyzed cyclization process for bicyclic β-lactams
ES2140384T3 (es) * 1990-09-13 2000-03-01 Lilly Co Eli Intermedios para 1-carbacefalosporinas y procedimiento para su preparacion.
US5089610A (en) * 1991-04-25 1992-02-18 Eli Lilly And Company Ring-closure method for 1-carbacephalosporin six-membered ring
US5521307A (en) * 1992-02-18 1996-05-28 Eli Lilly And Company Methods and compounds for the preparation of carbacephems
JP4212112B2 (ja) 1996-02-23 2009-01-21 イーライ・リリー・アンド・カンパニー 非ペプチジルバソプレッシンＶ１ａアンタゴニスト
AU4224699A (en) 1999-01-27 2000-08-18 Pharmacia & Upjohn Company Assays for modulators of elongation factor p activity
JP4916929B2 (ja) * 2007-03-23 2012-04-18 ヤマハ発動機株式会社 直交型ロボット
NZ583970A (en) 2007-10-11 2011-04-29 Univ California Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase
WO2012003436A1 (en) 2010-07-01 2012-01-05 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
WO2014144547A2 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
WO2014144836A2 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors
CA2944211C (en) 2014-03-28 2022-10-04 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
US20190321363A1 (en) * 2016-06-20 2019-10-24 Dr. Reddy's Laboratories Limited Process for the preparation of elagolix sodium and its polymorph
CN112500361B (zh) * 2020-12-27 2023-05-12 甘肃瀚聚药业有限公司 一种(s)-4-苯基-2-恶唑烷酮的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226866A (en) * 1972-11-06 1980-10-07 Merck & Co., Inc. Novel antibiotic analogues of cephalosporins
US4166816A (en) * 1975-05-05 1979-09-04 Smithkline Corporation Methods and intermediates for preparing cis-4-oxoazetidine intermediates
US4200572A (en) * 1975-09-03 1980-04-29 Smithkline Corporation Substituted azetidinones
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
US4174316A (en) * 1978-08-14 1979-11-13 Merck & Co., Inc. 4-Iodomethylazetidin-2-one
US4472576A (en) * 1982-12-03 1984-09-18 Merck & Co., Inc. Processes for the production of antibiotic 1-oxadethiacephalosporins
US4502994A (en) 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
US4673737A (en) 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
AU6016686A (en) 1987-01-22
JPS6242985A (ja) 1987-02-24
ATE133172T1 (de) 1996-02-15
DE3650474D1 (de) 1996-02-29
HK1007140A1 (en) 1999-04-01
CA1310323C (en) 1992-11-17
US4665171A (en) 1987-05-12
HUT41786A (en) 1987-05-28
EP0362902A3 (en) 1990-08-01
JPH07300476A (ja) 1995-11-14
ES2005752A6 (es) 1989-03-16
KR870001193A (ko) 1987-03-12
IL79420A (en) 1992-01-15
AU619938B2 (en) 1992-02-06
SU1579460A3 (ru) 1990-07-15
DK16096A (da) 1996-02-15
PT82989B (pt) 1989-01-30
DE3679002D1 (de) 1991-06-06
DK335686D0 (da) 1986-07-15
IE861900L (en) 1987-01-17
EP0209352B1 (en) 1991-05-02
EP0209352A2 (en) 1987-01-21
CN1015178B (zh) 1991-12-25
EP0362902A2 (en) 1990-04-11
DK173456B1 (da) 2000-11-27
NZ216871A (en) 1989-10-27
EP0209352A3 (en) 1988-04-20
AU595216B2 (en) 1990-03-29
IE58997B1 (en) 1993-12-15
JPH0762015B2 (ja) 1995-07-05
KR900005257B1 (ko) 1990-07-21
GR861857B (en) 1986-11-18
HU906465D0 (en) 1991-04-29
JP2634775B2 (ja) 1997-07-30
ZA865274B (en) 1988-02-24
RU1794079C (ru) 1993-02-07
PT82989A (en) 1986-08-01
CN86104783A (zh) 1987-02-04
AR243186A1 (es) 1993-07-30
ATE63118T1 (de) 1991-05-15
DE3650474T2 (de) 1996-06-13
AU4793490A (en) 1990-05-10
DK335686A (da) 1987-02-25
HU201931B (en) 1991-01-28
EP0362902B1 (en) 1996-01-17

Similar Documents

Publication Publication Date Title
ES2000516A6 (es) Un procedimiento asimetrico para la preparacion de 1-carbacefalosporinas
GR861858B (en) Intermediates and process for antibiotics
AU570002B2 (en) Indol-3-yl carboxylic acid tropyl ester
ES8802613A1 (es) Procedimiento para la obtencion del acido 1-ciclopropil-6-fluor-1,4-dihidro-7-(4-isopropil-1-piperazinil)-4-oxo-3-quinolincarboxilico
AU590321B2 (en) Improved process for tetrafluorobenzoic acid
AU2581188A (en) Apparatus for editing video tapes
AU566245B2 (en) B- lactam antibiotic stabilized with carbon dioxide
ES2001338A6 (es) Un procedimiento para la preparacion de un solvato cristalino con dimetilformamida del acido 7-(d)-2-amino-2-(4-hidroxifenil) acetamido -3-(z)-1-propenil cef -3-em-4-carboxilico.
AU1258888A (en) Process for esters of 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
AU566096B2 (en) Cephalosporin ester derivatives
PT80715B (en) Process for preparing cephalosporin antibiotics
IE880255L (en) Des-epidermal growth factor activators.
MY114213A (en) Clavulanic acid salts
AU646436B2 (en) Processes for preparing 2-halogeno-3-hydroxy-3- phenylpropionic acid ester compounds
AU2685184A (en) Polycyclic carboxylic acid derivatives
AU571042B2 (en) Cephalosporin esters
AU1769288A (en) 7-aminocephalosporanic acid derivatives
AU2055588A (en) Magnetic shunt for deflection yokes
AU560544B2 (en) Heterocyclic acetic acid esters
AU569142B2 (en) Apparatus for driving tapes
AU5646080A (en) (+)-(3-methyl-4-oxo - 5n-piperidinothiazolidin-2-ylidene) acetic acid esters
AU2499188A (en) Apparatus for maintaining fuel injections
AU1259488A (en) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts